|Day Low/High||61.75 / 62.21|
|52 Wk Low/High||56.61 / 68.60|
All three indices are gaining steam after yesterday's big down day.
Jim Cramer looks at General Mills and General Electric, but he only backs one of them.
Speculative investors have misled the market in the face of very real dangers. Don't be one of them.
Nicole Urken and Scott Redler, chief strategic officer at T3Live.com, reveal how to trade stocks ahead of earnings season: retail, banks, tech.
Here's a quick roundup of earnings from stocks we've recommended. The news has been uniformly good.
Procter, Colgate, Clorox, Pepsi and Kellogg are all performing well. A possible warning sign over the short term is the strength in defensive, consumer staples shares today, including Procter & Gamble (PG), Colgate-Palmolive (CL), Clorox (CLX), Peps...
As the market reopens, I'm sizing up how the storm has affected stocks and the economy.
Conservative investors who miss their old bank CD rates might wish to partake in Kellogg.
Nicole Urken, Research Associate for Jim Cramer, says all signs point to an opportunity in Kellogg.
Stephanie Link, director of research at TheStreet, is an owner of both Mondelez and Kraft after the spin-off, she how she's trading them in this video.
Kellogg, a preeminent all-weather company, stands to remain a solid performer this year.
We see good strength across the board in defensive staples. The kids in Bristol are sharp as a pistol When they do the Bristol Stomp Really somethin' when they join in jumpin' When they do the Bristol Stomp Whoa, whoa they start spinnin' every Frida...
A possible first-quarter 2013 approval for Eliquis could be an important catalyst for the shares. This week I have written about an expected rotation into defensive staples. We saw a glimpse of it yesterday, and we are witnessing more today -- Proct...
Every single defensive stock on my screen is in the green. The rotation into consumer staples is continuing to day with every single defensive stock on my scdreen in the green -- Colgate-Palmolive (CL), Clorox (CLX), Procter & Gamble (PG), Internati...
None of these tools have anything to do with owning four flatscreen computer monitors.
Jim Cramer goes against the Goldman Sachs call to upgrade Campbell's Soup to a 'Buy' from a 'Sell'.
Today we are lifting the high-dividend end of our barbell approach, and recommending Con Ed, Dominion Resources and Kellogg.
Too many longs. I now am long about 45 individual equity names. That is too many, I am simply too diversified. Today I plan to reduce my holdings down to approximately 30 positions by eliminating some holdings and by adding to those in which I am mo...
Currently, 42 out of the 66 stocks are now eligible to buy (down from 46 out of 65 two weeks ago). Below is an updated list of buy levels on selected stocks that I have mentioned on Real Money Pro. Of the 66 stocks monitored, I would now rate 42 (do...
I have set up three tracking portfolios to test how a completely hedged portfolio that relies on outperforming the market will perform.
Kellogg and Fusion-io get some analysts' attention. Barclays reinstates an Equal Weight on Kellogg (K), with a price target of $48.25, and Sterne Agee upgrades Fusion-io (FIO) to Buy from Neutral, with a price target of $24.
Pick up positions with good, reasonable valuations, non-cyclical revenue streams and solid balance sheets.